RESUMEN
Minerals are essential for life, as they are a vital part of protein constituents, enzyme cofactors, and other components in living organisms. Deep sea water is characterized by its cleanliness and stable low temperature, and its possible health- and medical benefits are being studied. However, no study has yet evaluated the physical properties of the numerous commercially available deep sea water products, which have varying water sources and production methods. We analyzed these products' mineral content and investigated their effect on living organism, focusing on immune functions, and investigated the relation between physiological immunoactivities and mineral intake. We qualitatively analyzed the mineral compositions of the deep sea water drinks and evaluated the drinks' physical properties using principal component analysis, a type of multivariate analysis, of their mineral content. We create an iron and copper-deficient rat model and administered deep sea water drinks for 8 weeks. We then measured their fecal immunoglobulin A (IgA) to evaluate immune function. Principal component analysis suggested that physical properties of deep sea water drinks could be determined by their sources. Administration of deep sea water drinks increased fecal IgA, thus tending to stimulate immune function, but the extent of this effect varied by drink. Of the minerals contained in deep sea water, iron showed positive correlations with the fecal IgA. The principal component analysis used in this study is suitable for evaluating deep sea water containing many minerals, and our results form a useful basis for comparative evaluations of deep sea water's bioactivity.
Asunto(s)
Bebidas , Inmunoglobulina A/inmunología , Intestinos/inmunología , Minerales/farmacología , Agua de Mar , Animales , Bebidas/análisis , Cobre , Dieta , Heces/química , Hierro , Masculino , Minerales/análisis , Ratas Wistar , Agua de Mar/análisisRESUMEN
We previously prepared and pharmaceutically evaluated ginger orally disintegrating (OD) tablets, optimized the base formulation, and carried out a clinical trial in healthy adults in their 20 s and 50s to measure their effect on salivary substance P (SP) level and improved swallowing function. In this study, we conducted clinical trials using the ginger OD tablets in older people to clinically evaluate the improvements in swallowing function resulting from the functional components of the tablet. The ginger OD tablets were prepared by mixing the excipients with the same amount of mannitol and sucrose to a concentration of 1% ginger. Eighteen healthy older adult volunteers aged 63 to 90 were included in the swallowing function test. Saliva was collected before and 15 min after administration of the placebo and ginger OD tablets. Swallowing endoscopy was performed by an otolaryngologist before administration and 15 min after administration of the ginger OD tablets. A scoring method was used to evaluate the endoscopic swallowing. Fifteen minutes after taking the ginger OD tablets, the salivary SP amount was significantly higher than prior to ingestion or after taking the placebo (p<0.05). Among 10 subjects, one scored 1-3 using the four evaluation criteria. Overall, no aspiration occurred and a significant improvement in the swallowing function score was observed (p<0.05) after taking the ginger OD tablets. Our findings showed that the ginger OD tablets increased the salivary SP amount and improved swallowing function in older people with appreciably reduced swallowing function.
Asunto(s)
Deglución/efectos de los fármacos , Preparaciones de Plantas/administración & dosificación , Zingiber officinale , Administración Oral , Anciano , Anciano de 80 o más Años , Catecoles/administración & dosificación , Catecoles/análisis , Catecoles/farmacología , Excipientes/química , Alcoholes Grasos/administración & dosificación , Alcoholes Grasos/análisis , Alcoholes Grasos/farmacología , Femenino , Humanos , Masculino , Manitol/química , Persona de Mediana Edad , Preparaciones de Plantas/química , Preparaciones de Plantas/farmacología , Polvos , Saliva/metabolismo , Solubilidad , Sustancia P/metabolismo , Sacarosa/química , Canales Catiónicos TRPV/agonistas , ComprimidosRESUMEN
The introduction of generic drugs is promoted from the perspective of medical economics. In this context, we need to understand not only the bioequivalence of generic drugs specified in "the Guidelines for Bioequivalence Studies of Generic Products", but also formulation properties to consider their effect on pharmacological therapy. We evaluated the pharmaceutical characteristics of rebamipide formulations, a brand-name drug and two generic drugs, and their clinical functionality by using rat models of gastric mucosal injury induced by non-steroidal anti-inflammatory drugs (NSAIDs). Pharmaceutical evaluation showed significant differences in hardness. The inter-lot variation was small in all rebamipide formulations. In the clinical functionality study, biochemistry test values 7 d after the administration of rebamipide showed no differences among formulations. Higher levels of mucosal fluid secretion and antioxidative enzymes were observed in the groups administered rebamipide than in the control group. The levels of lipid peroxide were lower in the groups administered rebamipide than the control group. Multivariate analysis showed slight divergence between the brand-name and generic drugs. In future, it will be necessary to select generic drugs after careful consideration of bioequivalence, clinical functionality, and therapeutic equivalence by reviewing scientific evidence such as indication and formulation design, not to mention stable provision.
Asunto(s)
Alanina/análogos & derivados , Antiulcerosos/farmacocinética , Antiulcerosos/uso terapéutico , Medicamentos Genéricos/farmacología , Medicamentos Genéricos/uso terapéutico , Quinolonas/farmacocinética , Quinolonas/uso terapéutico , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/tratamiento farmacológico , Alanina/farmacocinética , Alanina/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/efectos adversos , Modelos Animales de Enfermedad , Composición de Medicamentos , Medicamentos Genéricos/farmacocinética , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/metabolismo , Indometacina/efectos adversos , Peróxidos Lipídicos/metabolismo , Masculino , Ratas Wistar , Úlcera Gástrica/metabolismo , Equivalencia TerapéuticaRESUMEN
Bangle (Zingiber purpureum) is a tropical ginger that is used as a spice in Southeast Asia. Phenylbutenoid dimers isolated from Bangle have exhibited neurotrophic effects in primary cultured rat cortical neurons and PC12 cells. Furthermore, chronic treatment with phenylbutenoid dimers enhances hippocampal neurogenesis in olfactory bulbectomized mice. In this study, we investigated the effects of Bangle extract on behavior and hippocampal neurogenesis in vivo. SAMP8 mice, which are an established model for accelerated aging, with age-related learning and memory impairments, were given a Bangle-containing diet for 1 month, and subsequent behavioral tests and immunohistochemistry for Ki67, a proliferating cell marker, were performed. We found that the Bangle-containing diet improved spatial learning and memory deficits in the Morris water maze and significantly increased the numbers of Ki67-positive cells in the dentate gyrus of the SAMP8 mice. In addition, the Bangle extract exhibited a neurotrophin-like activity as indicated by the induction of neurite sprouting in PC12 cells. Our results suggest that Bangle is beneficial for the prevention of age-related progression of cognitive impairment.
Asunto(s)
Envejecimiento/efectos de los fármacos , Trastornos de la Memoria/tratamiento farmacológico , Neurogénesis/efectos de los fármacos , Neuronas/efectos de los fármacos , Aprendizaje Espacial/efectos de los fármacos , Zingiberaceae/química , Envejecimiento/psicología , Animales , Giro Dentado/efectos de los fármacos , Giro Dentado/fisiopatología , Modelos Animales de Enfermedad , Humanos , Masculino , Memoria/efectos de los fármacos , Trastornos de la Memoria/fisiopatología , Trastornos de la Memoria/psicología , Ratones , Ratones Transgénicos , Neuronas/citología , Células PC12 , RatasRESUMEN
During the postpartum period there is a high incidence of mastitis in dairy cows. The reason for this increased risk of mastitis still remains unclear. Since leukocytes in colostrum have an important role in preventing the onset of mastitis, we investigated the leukocyte populations, which express CD4, CD8, CD14, CD21 or WC1, in colostrum as well as in blood obtained from 14 Holstein cows. Eight cows developed mastitis within a week after calving and the other 6 remained healthy. The percentage of CD14+ cells in colostrum was significantly lower in mastitic cows than in healthy cows. There were no significant differences in other marker positive cells either in the colostrum or in the blood. The CD14+ cells in colostrum play an important role of defense against invading microorganisms in the mammary glands. Our results suggested that the lower percentage of CD14+ cells in colostrum might predict the incidence of mastitis in the following period.